http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Sun, 24 Nov 2024 19:27:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.md.roclle" idsrc="xmltag.org" >ROCKVILLE, Md.</location> and SUZHOU, <location value="LC/cn" idsrc="xmltag.org" >China</location></span>, <span class="legendSpanClass"><chron>Nov. 24, 2024</chron></span> /PRNewswire/ -- <span value="HongKong:6855" idsrc="xmltag.org" >Ascentage Pharma</span> (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed Ms. <person value="APIN:4203534576">Marina S. Bozilenko</person> and Dr. <person>Debra Yu</person> as additional independent non-executive directors of the company with effect from <chron>November 25, 2024</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Ascentage+Pharma+Appoints+Ms.+Marina+S.+Bozilenko+and+Dr.+Debra+Yu+as+Independent+Non-Executive+Directors/24024703.html Sun, 24 Nov 2024 19:27:00 -0400 6855 A.06372891 A.06822034 A.07309385 A.10141387 A.10301130 A.21285025 A.23936186 A.27822871 A.31465185 A.33615634 A.35954321 A.60001765 LIAN LIANY MGTX O.01883622 O.02713679 O.02829901 O.04698756 O.04944854 O.07116439 O.20026344 O.20043539 O.20737027 O.22666513 O.29998564 O.30537446 O.38659577 O.49219591 O.52503057 OLMA SYNACT TLPH